Tag: Keytruda expiration
Blockbuster Patent Expirations 2025 and Beyond: Key Drugs, Timeline, and Market Impact
Blockbuster drug patents expire in 2025 and beyond, triggering massive price drops for heart, cancer, and autoimmune treatments. Keytruda, Entresto, and Eliquis are among the top drugs losing protection - here's what it means for patients, providers, and prices.
Blockbuster Patent Expirations 2025 and Beyond: Key Drugs, Timeline, and Market Impact
In 2025 and beyond, dozens of top-selling drugs like Entresto, Eliquis, and Keytruda lose patent protection, triggering massive price drops and biosimilar competition. Here's the full timeline and what it means for patients, pharmacies, and drugmakers.
